Garofalo Elizabeth A.'s Form 4 filing
Xenon Pharmaceuticals Inc. (XENE) · filed Mar 11, 2024
- Accession no.
- 0000950170-24-029542
- Filed
- Mar 11, 2024
- Trade date
- Mar 8, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $95.6K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Garofalo Elizabeth A.CIK 0001826361 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2024 | Common Shares | MOption exerciseAcquired | +3,500 | $18.56 | +$64,960 | 3,500 | Direct | |
| Mar 8, 2024 | Common Shares | FTax withholdingDisposed | −1,408 | $46.16 | −$64,993.28 | 2,092 | Direct | |
| Mar 8, 2024 | Common Shares | SSaleDisposed | −2,092 | $45.69 | −$95,583.48 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2024 | Common Shares | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 16,500 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.